-transparent.png){kind=logo}
The bioaccessibility of Soviet produced digoxin tablets in elderly patients with cardiac insufficiency was studied. It is shown that in absolute bioaccessibility (62%) and other biopharmaceutic indices digoxin tablets made in the Soviet Union are equivalent to lanoxin tablets of the Burroughs Wellcome firm which are accepted by the USA FDA as the bioaccessibility standard. Equations fitted within a two-part mathematical model satisfactorily describe the changes in blood serum digoxin concentration in oral medication and in intravenous administration.
Related Publications
L E Kholodov, and
E A Grigor'eva, and
M G Glezer, and
E A Sabel'nikova
January 1973,
Clinical pharmacology and therapeutics,
L E Kholodov, and
E A Grigor'eva, and
M G Glezer, and
E A Sabel'nikova
June 1973,
Pharmacological reviews,
L E Kholodov, and
E A Grigor'eva, and
M G Glezer, and
E A Sabel'nikova
January 1978,
Arzneimittel-Forschung,
L E Kholodov, and
E A Grigor'eva, and
M G Glezer, and
E A Sabel'nikova
August 1975,
Harefuah,
L E Kholodov, and
E A Grigor'eva, and
M G Glezer, and
E A Sabel'nikova
November 1974,
Acta pharmaceutica Suecica,
L E Kholodov, and
E A Grigor'eva, and
M G Glezer, and
E A Sabel'nikova
July 1980,
The American journal of medicine,
L E Kholodov, and
E A Grigor'eva, and
M G Glezer, and
E A Sabel'nikova
January 1979,
Journal of pharmaceutical sciences,
L E Kholodov, and
E A Grigor'eva, and
M G Glezer, and
E A Sabel'nikova
December 1973,
The Journal of pharmacy and pharmacology,
L E Kholodov, and
E A Grigor'eva, and
M G Glezer, and
E A Sabel'nikova
April 1994,
Archives of pharmacal research,
L E Kholodov, and
E A Grigor'eva, and
M G Glezer, and
E A Sabel'nikova
June 1973,
Lancet (London, England),
